New trial aims to standardize heart valve repair for common birth defect
NCT ID NCT06869954
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This clinical trial is testing two different surgical methods to repair a bicuspid aortic valve, a common heart defect where the valve has two flaps instead of three. The study will enroll 100 people with this condition who also have a leaky valve (aortic regurgitation). Half will receive an internal ring device, and the other half an external ring, to see which approach leads to better blood flow and less leakage after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HAART 200 internal annuloplasty device and external annuloplasty ring
What this could lead to
If successful, this trial could establish a more standardized and effective surgical repair technique for bicuspid aortic valve regurgitation, potentially reducing the need for repeat surgeries.
What could go wrong
This is a relatively small, early-stage trial (100 participants) comparing two surgical methods. The results may not apply to all patients, and both procedures carry standard surgical risks like infection or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BICUSPID AORTIC VALVE (BAV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heart Center Leipzig
NOT_YET_RECRUITINGLeipzig, Saxony, 04289, Germany
Contact
-
Medical Center Hamburg-Eppendorf
RECRUITINGHamburg, 20246, Germany
Contact Email: •••••@•••••
-
University Heart and Vascular Center Frankfurt
NOT_YET_RECRUITINGFrankfurt am Main, Hesse, 60598, Germany
Contact
-
University Hospital Augsburg
RECRUITINGAugsburg, Bavaria, 86156, Germany
Contact Email: •••••@•••••